Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Will 2023 be the year that pharma M&A makes a comeback? By: MarketWatch January 12, 2023 at 13:29 PM EST A handful of acquisitions this week point to a more deal-friendly year for biopharma and biotech companies. Read More >> Related Stocks: Albireo Pharma Inc Amgen Amryt Pharma Plc ADR Apellis Pharmaceuticals Inc Astrazeneca Plc ADR Biontech Se ADR CinCor Pharma, Inc. - Common Stock Horizon Therapeutics Karuna Therapeutics Inc S&P Biotech SPDR S&P Pharmaceuticals SPDR Xenon Pharmaceuticals Inc Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Will 2023 be the year that pharma M&A makes a comeback? By: MarketWatch January 12, 2023 at 13:29 PM EST A handful of acquisitions this week point to a more deal-friendly year for biopharma and biotech companies. Read More >> Related Stocks: Albireo Pharma Inc Amgen Amryt Pharma Plc ADR Apellis Pharmaceuticals Inc Astrazeneca Plc ADR Biontech Se ADR CinCor Pharma, Inc. - Common Stock Horizon Therapeutics Karuna Therapeutics Inc S&P Biotech SPDR S&P Pharmaceuticals SPDR Xenon Pharmaceuticals Inc